SCHEDULE: Cormorant Asset Management Reports 0% Stake in KALA BIO

Cormorant Asset Management, LP and Bihua Chen filed an amended Schedule 13G, reporting zero beneficial ownership in KALA BIO, Inc.'s common stock as of September 30, 2025.

Summary

• Cormorant Asset Management, LP and Bihua Chen, collectively referred to as the Reporting Persons, filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership in KALA BIO, Inc.
• The filing indicates that as of September 30, 2025, the Reporting Persons beneficially own 0 shares of KALA BIO, Inc.'s Common Stock, representing 0% of the class.
• Both Cormorant Asset Management, LP and Bihua Chen report having 0 sole voting power, 0 shared voting power, 0 sole dispositive power, and 0 shared dispositive power.
• Cormorant Asset Management, LP is a Delaware limited partnership and an investment adviser, while Bihua Chen is a U.S. citizen.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 5

Explanation: The filing reports that Cormorant Asset Management, LP and Bihua Chen beneficially own 0% of KALA BIO, Inc.'s common stock. This indicates a complete divestment or reduction below the reporting threshold, which is a neutral event in terms of the company's operational performance or strategic direction.

Future Outlook

NA

Industry Context

NA

Key Dates

Keywords

KALA BIO Inc., Cormorant Asset Management, Bihua Chen, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, SEC Filing